Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots

Supreme Court rejects appeals brought by RFK Jr-founded anti-vaccine group over Covid shots


Independent Presidential candidate Robert F. Kennedy Jr. speaks during a campaign rally at Legends Event Center on December 20, 2023 in Phoenix, Arizona. 

Rebecca Noble | Getty Images

The Supreme Court on Monday turned away two Covid-related appeals brought by Children’s Health Defense, the anti-vaccine group founded by independent presidential candidate Robert F. Kennedy Jr.

The decision by the justices not to hear the cases leaves in place lower court rulings against the group.

One case challenged the Food and Drug Administration’s emergency authorization of Covid-19 vaccines in December 2020, while the other was brought against Rutgers University in New Jersey over its Covid-19 vaccine mandate.

In the FDA case, the group claimed in court papers that Covid vaccines were “ineffective and lacked proper vetting.” The New Orleans-based 5th U.S. Circuit Court of Appeals found that Kennedy’s group did not have legal standing to sue.

In the Rutgers dispute, the Philadelphia-based 3rd U.S. Circuit Court of Appeals concluded that the plaintiffs “have not stated any plausible claim for relief.”

Kennedy himself took leave from the group he founded in April 2023 to run for president. He failed to make inroads in the Democratic primaries and is now running as an independent.

On the campaign trail he has mostly downplayed his anti-vaccine, activity but in November he spoke at a Children’s Health Defense conference.

Kennedy is listed as a lawyer on the Rutgers filing at the Supreme Court despite his leave of absence from the group.

In a separate vaccine-related case, the court also turned away a challenge to Connecticut’s decision to repeal a religious exemption for school vaccinations.



Source

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
Health

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]

Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More
Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’
Health

Trump threatens to impose up to 200% tariff on pharmaceuticals ‘very soon’

U.S. President Donald Trump speaks next to Defense Secretary Pete Hegseth during a cabinet meeting at the White House in Washington, D.C., U.S., July 8, 2025. Kevin Lamarque | Reuters President Donald Trump on Tuesday threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S. “very soon.”  “They’re going to be tariffs […]

Read More